Physician

Albert Roy Katz, M.D.

According to 2025 Medicare claims, Albert Katz, M.D. (NPI: 1699737932) practices rheumatology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. Katz uses personal NPI as billing NPI and primary practice location at 91356-9998.

Katz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 196 traditional Medicare patients, billed 916 HCPCS/CPT codes, and received $96,222 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,225 prescription claims across 229 beneficiaries totaling $1,088,960 in drug costs, led by Humira(Cf) Pen (Adalimumab). DME data shows 30 claims. Open Payments data shows 121 records totaling $3,312. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $135,869 and ending at $96,222. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $577,024 to $1,088,960. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $1,333 to $2,119.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	339	1,570	$135,869
2016	315	1,584	$118,713
2017	314	1,425	$111,240
2018	323	1,774	$145,309
2019	316	1,818	$162,140
2020	243	1,369	$126,061
2021	255	1,567	$155,406
2022	238	1,338	$129,494
2023	212	986	$109,575
2024	196	916	$96,222

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	261	2,908	$577,024
2016	254	2,870	$530,773
2017	222	2,531	$650,958
2018	215	2,486	$665,296
2019	247	2,550	$614,546
2020	202	2,732	$568,335
2021	190	2,135	$508,472
2022	226	2,287	$889,963
2023	236	2,390	$1,386,059
2024	229	2,225	$1,088,960

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	31	$1,189
2021	N/R	N/R	N/R
2022	N/R	42	$1,361
2023	N/R	37	$2,039
2024	N/R	30	$1,521

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	118	367	$132
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	62	71	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	49	81	$90
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	62	225	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	36	74	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	18	504	$121,655
Benlysta	Belimumab	25	700	$120,153
Enbrel	Etanercept	13	364	$92,855
Rinvoq	Upadacitinib	14	420	$86,740
Prolia	Denosumab	29	5,220	$49,311

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$1,028
E1392	Portable oxygen concentrator, rental	Y	N/R	15	$493

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	121	$3,312	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albert Roy Katz, M.D.?

Tedicare shows public-source Medicare data for Albert Roy Katz, M.D. (NPI 1699737932), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert Roy Katz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Albert Roy Katz, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Albert Roy Katz, M.D. have Open Payments data?

Albert Roy Katz, M.D. has 121 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.